NR 546 PSYCHOPHARM MIDTERM EXAM 2025 ACTUAL
EXAM COMPLETE 200 QUESTIONS WITH DETAILED
VERIFIED ANSWERS (100% CORRECT) /ALREADY GRADED
A+ // BRAND NEW!!
Question 1
Which neurotransmitter is primarily associated with the "reward pathway" in
the brain and plays a crucial role in motivation, pleasure, and addiction?
A) Serotonin (5-HT)
B) Dopamine (DA)
C) Norepinephrine (NE)
D) Gamma-aminobutyric acid (GABA)
E) Acetylcholine (ACh)
Correct Answer: B) Dopamine (DA)
Rationale: Dopamine is a key neurotransmitter in the mesolimbic
pathway, often referred to as the reward pathway, influencing
pleasure, motivation, and reinforcement learning, and is heavily
implicated in addiction.
Question 2
The process by which a drug is absorbed, distributed, metabolized, and
excreted by the body is known as:
A) Pharmacodynamics
B) Pharmacogenomics
C) Pharmacokinetics
D) Psychopharmacology
E) Neurotransmission
Correct Answer: C) Pharmacokinetics
Rationale: Pharmacokinetics (what the body does to the drug)
encompasses the processes of Absorption, Distribution, Metabolism,
and Excretion (ADME), determining the drug's concentration at its
site of action.
,Question 3
Which of the following describes the mechanism of action of a drug that
blocks the reuptake of a neurotransmitter, thereby increasing its
concentration in the synaptic cleft?
A) Receptor agonist
B) Receptor antagonist
C) Enzyme inhibitor
D) Reuptake inhibitor
E) Ion channel modulator
Correct Answer: D) Reuptake inhibitor
Rationale: A reuptake inhibitor blocks the transporter proteins
responsible for reabsorbing neurotransmitters from the synaptic
cleft back into the presynaptic neuron, leading to increased
neurotransmitter availability.
Question 4
A drug's "half-life" (t½) is best defined as the time it takes for:
A) The drug to reach its peak plasma concentration.
B) Half of the administered drug dose to be absorbed.
C) The amount of drug in the body to decrease by 50%.
D) The drug to exert half of its maximum therapeutic effect.
E) The drug to be completely eliminated from the body.
Correct Answer: C) The amount of drug in the body to decrease by
50%.
Rationale: Half-life is a critical pharmacokinetic parameter that
dictates how long a drug's effects will last and determines the
appropriate dosing interval to maintain therapeutic levels.
Question 5
Which cytochrome P450 (CYP450) enzyme is responsible for metabolizing the
largest number of psychotropic medications?
A) CYP1A2
,B) CYP2C9
C) CYP2D6
D) CYP3A4
E) CYP2C19
Correct Answer: D) CYP3A4
Rationale: CYP3A4 is the most abundant CYP450 enzyme in the
human liver and is involved in the metabolism of approximately 50%
of all clinically used drugs, including a significant portion of
psychotropics.
Question 6
A "receptor antagonist" in pharmacodynamics refers to a drug that:
A) Binds to a receptor and produces a maximal biological response.
B) Binds to a receptor but produces no intrinsic activity, preventing an
agonist from binding.
C) Binds to an allosteric site to enhance agonist binding.
D) Increases the synthesis of a neurotransmitter.
E) Accelerates the reuptake of a neurotransmitter.
Correct Answer: B) Binds to a receptor but produces no intrinsic
activity, preventing an agonist from binding.
Rationale: An antagonist occupies a receptor site without activating
it, thereby blocking the action of an agonist and preventing it from
producing its typical effect.
Question 7
The "therapeutic index" of a psychotropic medication is a measure of its:
A) Potency.
B) Efficacy.
C) Safety.
D) Bioavailability.
E) Half-life.
Correct Answer: C) Safety.
, Rationale: The therapeutic index is the ratio of a drug's toxic dose
(TD50) to its effective dose (ED50). A larger therapeutic index
indicates a wider margin of safety, while a narrow therapeutic index
requires careful monitoring.
Question 8
Which brain region is primarily associated with fear, anxiety, and the "fight
or flight" response?
A) Hippocampus
B) Thalamus
C) Amygdala
D) Cerebellum
E) Basal ganglia
Correct Answer: C) Amygdala
Rationale: The amygdala is a key brain structure involved in
processing emotions, particularly fear, and plays a central role in
anxiety disorders and the stress response.
Question 9
What is "steady state" in pharmacokinetics?
A) The initial peak concentration after a loading dose.
B) The point at which the amount of drug eliminated equals the amount
absorbed with each dose.
C) The time when the drug's side effects are most prominent.
D) The duration of the drug's therapeutic effect.
E) The lowest drug concentration observed between doses.
Correct Answer: B) The point at which the amount of drug eliminated
equals the amount absorbed with each dose.
Rationale: At steady state, drug accumulation stops, and plasma
concentrations fluctuate within a predictable range, typically
achieved after approximately 4-5 half-lives of the drug.
EXAM COMPLETE 200 QUESTIONS WITH DETAILED
VERIFIED ANSWERS (100% CORRECT) /ALREADY GRADED
A+ // BRAND NEW!!
Question 1
Which neurotransmitter is primarily associated with the "reward pathway" in
the brain and plays a crucial role in motivation, pleasure, and addiction?
A) Serotonin (5-HT)
B) Dopamine (DA)
C) Norepinephrine (NE)
D) Gamma-aminobutyric acid (GABA)
E) Acetylcholine (ACh)
Correct Answer: B) Dopamine (DA)
Rationale: Dopamine is a key neurotransmitter in the mesolimbic
pathway, often referred to as the reward pathway, influencing
pleasure, motivation, and reinforcement learning, and is heavily
implicated in addiction.
Question 2
The process by which a drug is absorbed, distributed, metabolized, and
excreted by the body is known as:
A) Pharmacodynamics
B) Pharmacogenomics
C) Pharmacokinetics
D) Psychopharmacology
E) Neurotransmission
Correct Answer: C) Pharmacokinetics
Rationale: Pharmacokinetics (what the body does to the drug)
encompasses the processes of Absorption, Distribution, Metabolism,
and Excretion (ADME), determining the drug's concentration at its
site of action.
,Question 3
Which of the following describes the mechanism of action of a drug that
blocks the reuptake of a neurotransmitter, thereby increasing its
concentration in the synaptic cleft?
A) Receptor agonist
B) Receptor antagonist
C) Enzyme inhibitor
D) Reuptake inhibitor
E) Ion channel modulator
Correct Answer: D) Reuptake inhibitor
Rationale: A reuptake inhibitor blocks the transporter proteins
responsible for reabsorbing neurotransmitters from the synaptic
cleft back into the presynaptic neuron, leading to increased
neurotransmitter availability.
Question 4
A drug's "half-life" (t½) is best defined as the time it takes for:
A) The drug to reach its peak plasma concentration.
B) Half of the administered drug dose to be absorbed.
C) The amount of drug in the body to decrease by 50%.
D) The drug to exert half of its maximum therapeutic effect.
E) The drug to be completely eliminated from the body.
Correct Answer: C) The amount of drug in the body to decrease by
50%.
Rationale: Half-life is a critical pharmacokinetic parameter that
dictates how long a drug's effects will last and determines the
appropriate dosing interval to maintain therapeutic levels.
Question 5
Which cytochrome P450 (CYP450) enzyme is responsible for metabolizing the
largest number of psychotropic medications?
A) CYP1A2
,B) CYP2C9
C) CYP2D6
D) CYP3A4
E) CYP2C19
Correct Answer: D) CYP3A4
Rationale: CYP3A4 is the most abundant CYP450 enzyme in the
human liver and is involved in the metabolism of approximately 50%
of all clinically used drugs, including a significant portion of
psychotropics.
Question 6
A "receptor antagonist" in pharmacodynamics refers to a drug that:
A) Binds to a receptor and produces a maximal biological response.
B) Binds to a receptor but produces no intrinsic activity, preventing an
agonist from binding.
C) Binds to an allosteric site to enhance agonist binding.
D) Increases the synthesis of a neurotransmitter.
E) Accelerates the reuptake of a neurotransmitter.
Correct Answer: B) Binds to a receptor but produces no intrinsic
activity, preventing an agonist from binding.
Rationale: An antagonist occupies a receptor site without activating
it, thereby blocking the action of an agonist and preventing it from
producing its typical effect.
Question 7
The "therapeutic index" of a psychotropic medication is a measure of its:
A) Potency.
B) Efficacy.
C) Safety.
D) Bioavailability.
E) Half-life.
Correct Answer: C) Safety.
, Rationale: The therapeutic index is the ratio of a drug's toxic dose
(TD50) to its effective dose (ED50). A larger therapeutic index
indicates a wider margin of safety, while a narrow therapeutic index
requires careful monitoring.
Question 8
Which brain region is primarily associated with fear, anxiety, and the "fight
or flight" response?
A) Hippocampus
B) Thalamus
C) Amygdala
D) Cerebellum
E) Basal ganglia
Correct Answer: C) Amygdala
Rationale: The amygdala is a key brain structure involved in
processing emotions, particularly fear, and plays a central role in
anxiety disorders and the stress response.
Question 9
What is "steady state" in pharmacokinetics?
A) The initial peak concentration after a loading dose.
B) The point at which the amount of drug eliminated equals the amount
absorbed with each dose.
C) The time when the drug's side effects are most prominent.
D) The duration of the drug's therapeutic effect.
E) The lowest drug concentration observed between doses.
Correct Answer: B) The point at which the amount of drug eliminated
equals the amount absorbed with each dose.
Rationale: At steady state, drug accumulation stops, and plasma
concentrations fluctuate within a predictable range, typically
achieved after approximately 4-5 half-lives of the drug.
